Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

New AI application reads eye movements

Eye movements read by a new AI application can reveal thoughts, memories, goals — and brain diseases.

16 Nov 2021

Researchers develop assessment tool to identify pain in nursing home residents with dementia

We know very little about the incidence of pain among the elderly in nursing homes. In Norway, no requirement is in place for pain to be assessed before or during nursing home admission, nor once a person has been admitted.

16 Nov 2021

Study: Daily low-dose aspirin is neither protective nor harmful regarding dementia risk

Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Study offers new insight into the role of tau proteins in ALS pathogenesis

A team led by investigators at Massachusetts General Hospital has shown that people living with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, who carry a mutation in the C9orf72 gene exhibit elevated levels of tau and phosphorylated tau protein in the motor cortex region of the brain.

15 Nov 2021

Scientists develop a promising new approach to potentially treat Alzheimer's disease

A promising new approach to potentially treat Alzheimer's disease – and also vaccinate against it – has been developed by a team of UK and German scientists.

15 Nov 2021

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

New research led by the University of Bristol, has shown the drug losartan, normally used to treat high blood pressure (hypertension), is not effective in slowing down the progression of Alzheimer's disease (AD) in people with mild-to-moderate disease after 12 months of treatment.

15 Nov 2021

Anticoagulation treatment may prevent cognitive decline in older atrial fibrillation patients

The anticoagulant medication dabigatran yielded similar results to warfarin for the prevention of cognitive decline in older adults with atrial fibrillation after two years of treatment, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Expert explores how our sleeping patterns can be linked to cognitive decline

Dr Greg Elder, Senior Lecturer in Psychology and Associate Director of Northumbria Sleep Research explores why a good night's sleep is important and how our sleeping patterns can be linked to conditions like dementia for The Conversation.

15 Nov 2021

Educational program on anticholinergic burden aims to improve health outcomes of older people

Falls, confusion, cognitive decline, dry mouth, constipation and urinary retention. In a new NPS MedicineWise podcast episode released today, Dr Kate Annear, NPS MedicineWise medical adviser and GP talks about the new NPS MedicineWise educational program on the cumulative effects of anticholinergic medicines.

15 Nov 2021

Study provides a new target for therapeutic intervention in Parkinson's disease

In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson's disease.

14 Nov 2021

£375 million Government funding to improve treatment for neurodegenerative diseases

People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, following a government commitment to invest £375 million over the next 5 years.

14 Nov 2021

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

12 Nov 2021

Researchers receive a five-year grant renewal to discover and validate VCID biomarkers

Researchers at the University of Kentucky's Sanders-Brown Center on Aging recently received a five-year grant renewal of their MarkVCID program from the National Institutes of Health (NIH). The award total is more than $6 million.

11 Nov 2021

New therapy harnesses "dancing molecules" to reverse paralysis, repair tissue after spinal cord injuries

Northwestern University investigators have developed a new injectable therapy that harnesses "dancing molecules" to reverse paralysis and repair tissue after severe spinal cord injuries.

11 Nov 2021

Johns Hopkins receives $20 million grant to develop technologies for healthy aging

Johns Hopkins has received a $20 million grant from the National Institute on Aging that will spur the development of artificial intelligence devices (AI) to improve the health of older adults and help them live independently for longer — a relatively untapped use of this technology.

11 Nov 2021

COVID-19 trends identified from multiple linked EHR

In this study, the sociodemographic factors, occurrence of health conditions, the effect of the first and second waves in England, and vaccination effects, were considered separately.

11 Nov 2021

New biomarkers could help determine synaptic damage and neurodegeneration in Alzheimer's

Alzheimer's disease is the main neurodegenerative disease in old people for which there is no treatment or efficient prevention yet.

10 Nov 2021

Cancer drugs could be repurposed as potential therapies for Alzheimer's disease

Existing and emerging cancer drugs could be repurposed as therapies to be tested in clinical trials for people at genetic risk of Alzheimer's disease, according to a new study published in Science Advances.

10 Nov 2021

Repeated listening to favorite music induces beneficial brain plasticity in Alzheimer’s patients

Researchers at the University of Toronto and Unity Health Toronto have demonstrated that repeated listening to personally meaningful music induces beneficial brain plasticity in patients with mild cognitive impairment or early Alzheimer's disease.

9 Nov 2021

Research opens the door to new therapeutic options for Parkinson's disease

These advances have been reported in a new scientific article published in the international journal Nature, fruit of the collaboration between Northwestern University (Chicago), Weill Cornell Medical College (New York) and the Institute of Biomedicine of Seville HUVR/CSIC/US/ and Ciberned.

8 Nov 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

New AI application reads eye movements

Researchers develop assessment tool to identify pain in nursing home residents with dementia

Study: Daily low-dose aspirin is neither protective nor harmful regarding dementia risk

Study offers new insight into the role of tau proteins in ALS pathogenesis

Scientists develop a promising new approach to potentially treat Alzheimer's disease

Common hypertension drug not effective in slowing down the progression of Alzheimer's disease

Anticoagulation treatment may prevent cognitive decline in older atrial fibrillation patients

Expert explores how our sleeping patterns can be linked to cognitive decline

Educational program on anticholinergic burden aims to improve health outcomes of older people

Study provides a new target for therapeutic intervention in Parkinson's disease

£375 million Government funding to improve treatment for neurodegenerative diseases

Will the future of global health rely upon addressing air pollution?

Researchers receive a five-year grant renewal to discover and validate VCID biomarkers

New therapy harnesses "dancing molecules" to reverse paralysis, repair tissue after spinal cord injuries

Johns Hopkins receives $20 million grant to develop technologies for healthy aging

COVID-19 trends identified from multiple linked EHR

New biomarkers could help determine synaptic damage and neurodegeneration in Alzheimer's

Cancer drugs could be repurposed as potential therapies for Alzheimer's disease

Repeated listening to favorite music induces beneficial brain plasticity in Alzheimer’s patients

Research opens the door to new therapeutic options for Parkinson's disease

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in